1. The First Pediatric Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Risk of Co-Infection with Other Respiratory Viruses
- Author
-
Hitoshi Okubo, Hiroaki Fujiyasu, Takahiro Kinebuchi, Iori Wakabayashi, Masayo Syouji, and Fujio Kakuya
- Subjects
Male ,0301 basic medicine ,Microbiology (medical) ,viruses ,Pneumonia, Viral ,030106 microbiology ,Disease ,medicine.disease_cause ,Virus ,Betacoronavirus ,03 medical and health sciences ,0302 clinical medicine ,Japan ,Human metapneumovirus ,Pandemic ,medicine ,Humans ,030212 general & internal medicine ,Child ,Lung ,Pandemics ,Respiratory Tract Infections ,Coronavirus ,biology ,Coinfection ,SARS-CoV-2 ,business.industry ,Mortality rate ,COVID-19 ,virus diseases ,General Medicine ,biology.organism_classification ,Virology ,Infectious Diseases ,medicine.anatomical_structure ,Infectious disease (medical specialty) ,Child, Preschool ,Coronavirus Infections ,business ,Respiratory tract - Abstract
Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, 3 children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the 3 patients experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered.
- Published
- 2020